期刊文献+

伊曲康唑对双氯芬酸在比格犬体内药动学的影响

Influence of Itraconazole on the Pharmacokinetics of Diclofenac in Beagle Dogs
下载PDF
导出
摘要 目的:研究伊曲康唑对双氯芬酸钠在比格犬体内药动学参数的影响。方法:采用随机交叉试验方法,一组口服双氯芬酸钠,另一组同时口服双氯芬酸钠和伊曲康唑,清洗期1周后,两组交叉服用药物。用HPLC法测定比格犬合用伊曲康唑前后双氯芬酸的血药浓度,并对其药动学参数进行分析。结果:较单独给予双氯芬酸钠,合用伊曲康唑使双氯芬酸钠血药浓度曲线下面积(AUC_(0–∞))与最大血药浓度C_(max)分别降低31%和42%。而达峰时间和半衰期并无显著差异(P>0.05)。结论:伊曲康唑可能通过影响双氯芬酸的胃肠道吸收过程,来影响AUC_(0–∞)和C_(max)。 Objective: To investigate the potential effect of itraconazole on the pharmacokinetics of diclofenac sodium in Beagle dogs after oral co-administration. Methods: A randomized and crossover study was performed in Beagle dogs. One group was with oral administration of diclofenac sodium,and the other was with oral co-administration of diclofenac sodium and itraconazole. After 1-week wash-out,the two groups were cross taken the drugs. The blood concentration of diclofenac in Beagle dogs before and after the combination with itraconazole was determined by HPLC,and the pharmacokinetic parameters were analyzed. Results: When compared with that of diclofenac sodium alone,the AUC_(0–∞)and C_(max)of diclofenac in the combination was decreased by 31% and 42%,respectively,while no statistically significant differences were observed in Tmaxand t1 /2of diclofenac between the treatment regimens. Conclusion:Itraconazole can reduce the AUC_(0–∞)and C_(max)of diclofenac through the influence on GIT absorption of diclofenac.
出处 《中国药师》 CAS 2016年第8期1467-1470,共4页 China Pharmacist
基金 四川省科技厅支撑项目(项目编号:16JY0192)
关键词 药动学参数 血药浓度 吸收 HPLC 双氯芬酸 伊曲康唑 Pharmacokinetic parameters Plasma concentration Absorption HPLC Diclofenac Itraconazole
  • 相关文献

参考文献12

  • 1乔明艳.国内双氯芬酸钠制剂开发概况[J].实用药物与临床,2010,13(5):379-380. 被引量:15
  • 2Lavand' homme PM, Roelants F,Waterloos H,et al. Postoperative anal- gesic effects of continuous wound infiltration with diclofenac after elec- tive cesarean delivery[ J]. Anesthesiology,2007,106(6) : 1220-1225.
  • 3Brodgen RN, Heel RC,Pakers GE,et al. Diclofenac sodium:a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin[J]. Drugs,1980,20(1) : 24-48.
  • 4Leemann T, Transon C, Dayer P. Cytochrome P450TB (CYP2C) : a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver[J]. Life Sci, 1993, 52(1) : 29-34.
  • 5Borga O, Borga B. Serum protein binding of nonsteroidal antiinflamma- tory drugs: A comparative study [ J ]. J Pharmacokinet Biopharm, 1997, 25(1) : 63-77.
  • 6Thompson GR 3rd, Cadena J, Patterson TF. Overview of Antifungal A- gents[ J]. Clin Chest Med,2009 ,30( 2 ) :203-215.
  • 7Olkkola KT, Backman JT, Neuvoneu PJ. Midazolam should be avoided in patients receiving the systemic antimycotics ketocouazole or itracon- azole[J]. Clin Pharmacol Ther, 1994; 55(5) : 481-485.
  • 8胡爱萍,胡国新,邱相君.反相高效液相色谱法检测人血浆中双氯芬酸钠的浓度[J].温州医学院学报,2005,35(4):330-331. 被引量:6
  • 9刘振威,胡卓汉,蔡映云.伊曲康唑对健康成人肝细胞微粒体细胞色素P450同工酶1A2、3A4活性的作用[J].中国临床药学杂志,2006,15(1):11-13. 被引量:4
  • 10苗彩云,陈漪,陈江飞.伊曲康唑影响的药代动力学相互作用研究进展[J].中国临床药理学与治疗学,2009,14(10):1183-1192. 被引量:9

二级参考文献100

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部